The importance of determining the complete genotype of patients with cystic fibrosis and, especially, identifying complex alleles in patients carrying the F508del mutation to predict the response to treatment and confirm the effectiveness of new combined complex CFTR modulators is emphasized [20]. This evidence concerns the gene CFTR and cystic fibrosis.